Let’s start up with the current stock price of Aerie Pharmaceuticals Inc. (AERI), which is $10.03 to be very precise. The Stock rose vividly during the last session to $11.79 after opening rate of $11.62 while the lowest price it went was recorded $11.40 before closing at $11.64.
Recently in News on September 29, 2020, Aerie Pharmaceuticals Announces Acceptance of Its Investigational New Drug Application for AR-15512 (TRPM8 Agonist) Eye Drop for Dry Eye Disease. Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases, today announced that the U.S. Food and Drug Administration (FDA) has reviewed the Investigational New Drug Application (IND) for AR-15512 (TRPM8 agonist) eye drop for dry eye and it is now in effect, allowing Aerie to initiate clinical studies in the treatment of dry eye. Aerie expects to initiate a Phase 2b clinical study in the fourth quarter of 2020. You can read further details here
Get Ready for my next COVID-19 stock idea. I have been very fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street catches on. Our goal for our members is to get our Alert’s first before the crowd.
Aerie Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $26.26 on 01/09/20, with the lowest value was $9.86 for the same time period, recorded on 10/19/20.
Aerie Pharmaceuticals Inc. (AERI) full year performance was -45.22%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Aerie Pharmaceuticals Inc. shares are logging -61.81% during the 52-week period from high price, and -1.86% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $10.22 and $26.26.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 863287 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Aerie Pharmaceuticals Inc. (AERI) recorded performance in the market was -51.84%, having the revenues showcasing -16.26% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 534.51M, as it employees total of 380 workers.
The Analysts eye on Aerie Pharmaceuticals Inc. (AERI)
During the last month, 0 analysts gave the Aerie Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 12.74, with a change in the price was noted -4.15. In a similar fashion, Aerie Pharmaceuticals Inc. posted a movement of -29.15% for the period of last 100 days, recording 736,406 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for AERI is recording 2.22 at the time of this writing. In addition, long term Debt to Equity ratio is set at 2.22.
Technical rundown of Aerie Pharmaceuticals Inc. (AERI)
Raw Stochastic average of Aerie Pharmaceuticals Inc. in the period of last 50 days is set at 6.02%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 7.90%. In the last 20 days, the company’s Stochastic %K was 30.41% and its Stochastic %D was recorded 37.34%.
Considering, the past performance of Aerie Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -51.84%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -21.03%, alongside a downfall of -45.22% for the period of the last 12 months. The shares increased approximately by -1.61% in the 7-day charts and went down by -1.27% in the period of the last 30 days. Common stock shares were lifted by -16.26% during last recorded quarter.